The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Hypertension: Developing Fixed-Dose Combination Drugs for Treatment.'' The purpose of this guidance is to assist sponsors in the clinical development of fixed-dose combination drugs for the treatment of hypertension. The guidance focuses on development of two-drug combinations of previously approved drugs.
Document
Hypertension: Developing Fixed-Dose Combination Drugs for Treatment; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Hypertension: Developing Fixed-Dose Combination Drugs...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 3735
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Hypertension: Developing Fixed-Dose Combination Drugs for Treatment; Draft Guidance for Industry; Availability,” thefederalregister.org (January 26, 2018), https://thefederalregister.org/documents/2018-01352/hypertension-developing-fixed-dose-combination-drugs-for-treatment-draft-guidance-for-industry-availability.